News
MOBI
14.25
-1.93%
-0.28
Mobia Medical Inc trading resumes
TipRanks · 3d ago
Mobia Medical Inc trading halted, volatility trading pause
TipRanks · 3d ago
Weekly Report: what happened at MOBI last week (0608-0612)?
Weekly Report · 3d ago
Top Executive Makes Bold Move With Fresh Mobia Medical Stock Purchase
TipRanks · 06/12 02:03
Mobia Medical CFO Curnes Nelson Bunker acquires 5,000 common shares worth $ 63,969
PUBT · 06/11 23:11
Weekly Report: what happened at MOBI last week (0601-0605)?
Weekly Report · 06/08 10:43
Primary Markets Group May 2026 U.S. IPO Monthly
Seeking Alpha · 06/07 14:05
Mobia Medical Q1 FY26 net loss widens 66.5% to $17.74 million; revenue more than doubled to $12.07 million
PUBT · 06/04 20:36
MOBIA MEDICAL INC <MOBI.O>: BOFA GLOBAL RESEARCH INITIATES COVERAGE WITH BUY RATING AND PRICE OBJECTIVE $16.00
Reuters · 06/02 12:53
MOBIA MEDICAL INC <MOBI.O>: BTIG INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $19
Reuters · 06/02 11:29
Mobia Medical initiated with a Buy at BofA with ‘long growth runway’
TipRanks · 06/02 10:26
Mobia Medical initiated with a Buy at BofA
TipRanks · 06/02 10:16
Mobia Medical initiated with an Overweight at JPMorgan
TipRanks · 06/02 09:15
Mobia Medical initiated with a Buy at Goldman Sachs
TipRanks · 06/02 08:21
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
Reuters · 06/02 07:49
MOBIA MEDICAL INC <MOBI.O>: JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $15
Reuters · 06/02 04:18
Weekly Report: what happened at MOBI last week (0525-0529)?
Weekly Report · 06/01 10:49
Weekly Report: what happened at MOBI last week (0518-0522)?
Weekly Report · 05/25 10:53
Weekly Report: what happened at MOBI last week (0511-0515)?
Weekly Report · 05/18 10:53
Major Investor Makes Bold Move in Mobia Medical Stock
TipRanks · 05/13 02:09
More
Webull provides a variety of real-time MOBI stock news. You can receive the latest news about Mobia Medical through multiple platforms. This information may help you make smarter investment decisions.
About MOBI
Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.